US2002164773A1PendingUtilityA1
Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
Priority: Oct 15, 1999Filed: Feb 26, 2002Published: Nov 7, 2002
Est. expiryOct 15, 2019(expired)· nominal 20-yr term from priority
A61P 37/04C12P 19/04A61P 3/10C12N 1/14A61K 36/07
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention describes new and distinct strains of higher Basidiomycetes mushrooms grown in submerged cultures. Specifically, the new strain of species of the genus Tremella offer superior yields of one-cell biomass and exocellular heteropolysaccharide glucuronoxylomannan, niacin and essential amino acids.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A process for producing a one cell biomass and exocellular polysaccharides of edible Basidiomycetes mushrooms, said process comprising: cultivating a fungi of the Basidiomycetes in submerged culture on nutrient media, and isolating the resulting biomass of edible Basidiomycetes and exocellular polysaccharides from the culture broth by alcohol precipitation.
2 . The process for producing a biomass and exocellular polysaccharides of edible Basidiomycetes mushrooms according to claim 1 , wherein the fungi of the Basidiomycetes is a species of the genus Tremella is selected from the group consisting of Tremella mesenterica.
3 . The process for producing a biomass of edible Basidiomycetes mushrooms and exocellular polysaccharide according to claim 1 , wherein the fungi of the Basidiomycetes produces nutrients comprising a hypoglycemic compound, essential amino acids or niacin.
4 . The process for producing a biomass of edible Basidiomycetes mushrooms according to claim 1 , wherein the nutrient media is of the following composition:
Medium A
Sucrose
25
Peptone
2.0
Yeast extract
2.25
KH 2 PO 4
1.0
MgSO 4 .7H 2 O
0.5
5 . The process for producing a biomass and exeocellular polysaccharides of edible Basidiomycetes mushrooms according to claim 1 , wherein the nutrient media is of the following composition:
Medium B
Sucrose
40
Peptone
1.0
Yeast extract
1.1
NaHPO 4 7H 2 O
1.0
NaH 2 PO 4 7H 2 O
0.5
KH 2 PO 4
1.0
Mg acetate
1.0
KC1
1.0
6 . The process for producing a biomass of edible Basidiomycetes mushrooms according to claim 1 , wherein the fungi is Tremella mesenterica CBS 101939.
7 . The process for producing a biomass of edible Basidiomycetes mushrooms according to claim 1 , wherein the fungi is selected from the group consisting of Tremella luciformis, T aurantia, T. encephala , and T. mesenterica.
8 . A composition for reducing blood levels of glucose in a mammal, said composition comprising a nutriceutical formulation of dried Basidiomycetes biomass.
9 . The composition according to claim 8 wherein the dried Basidiomycetes biomass comprises a glucose-lowering compound, glucuronoxylomannan, polysaccharide, fiber, protein, essential amino acids, vitamins or niacin.
10 . The composition according to claim 8 , wherein the dried Basidiomycetes biomass and exocellular polysaccharides is produced from Tremella mesenterica CB 101939.
11 . The composition according to claim 8 , wherein the dried Basidiomycetes biomass and is produced from a fungi selected from the group consisting of Tremella luciformis, T. aurantia, T. encephala , and T. mesenterica.
12 . The composition according to claim 8 wherein the dried Basidiomycetes biomass and exocellular polysaccharides is used in an effective amount to reduce blood levels of glucose, in combination with a pharmaceutical carrier acceptable for oral administration.
13 . The composition according to claim 8 wherein the dried Basidiomycetes biomass and exocellular polysaccharides is used in an effective amount to inhibit diabetes.
14 . The composition according to claim 8 wherein the dried Basidiomycetes biomass and exocellular polysaccharides is used in an effective amount to inhibit a variety of diseases including human immunodeficiency.
15 . A method for treating an individual for hyperglycemia, said method comprising: administering to said individual an amount effective to reduce the level of serum glucose, of a composition containing an edible biomass of Basidiomycetes and exocellular polysaccharides, wherein said product includes a glucose-lowering compound.
16 . The method according to claim 15 , wherein said amount is effective to reduce the level of blood glucose from about 20% to 50%.
17 . The method according to claim 15 , wherein the biomass of Basidiomycetes is produced from fungi of a species of the genus Tremella.
18 . The method according to claim 17 wherein the species of the fungi is selected from the group consisting of Tremella luciformis, T. aurantia, T. encephala , and T. mesenterica.
19 . The method according to claim 14 wherein the Basidiomycetes biomass is produced from Tremella mesenterica CB 101939.Join the waitlist — get patent alerts
Track US2002164773A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.